---
figid: PMC4068075__1939-4551-7-13-3
figtitle: Consequences of EMT on innate signaling
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Respiratory syncytial virus
organisms_ner:
- Rattus norvegicus
- Homo sapiens
- Mus musculus
- Danio rerio
pmcid: PMC4068075
filename: 1939-4551-7-13-3.jpg
figlink: /pmc/articles/PMC4068075/figure/F3/
number: F3
caption: Consequences of EMT on innate signaling. The innate NFkB pathway is composed
  of the rapidly responding (canonical)- and the slower responding (noncanonical)
  pathways. The canonical pathway controls the inflammatory response, and is coupled
  to the noncanonical pathway through a feed-forward pathway by the synthesis of TRAF1
  and NFκB2, two rate limiting factors in noncanonical pathway activation. Through
  epigenetic reprogramming and enhanced transcriptional elongation through the cyclin
  dependent kinase (CDK), the rate-limiting TRAF1/NFκB2 translation is reduced, resulting
  in enhanced pathway activation in EMT.
papertitle: Systems biology approaches to understanding Epithelial Mesenchymal Transition
  (EMT) in mucosal remodeling and signaling in asthma.
reftext: Talha Ijaz, et al. World Allergy Organ J. 2014;7(1):13-13.
year: '2014'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9323915
figid_alias: PMC4068075__F3
figtype: Figure
redirect_from: /figures/PMC4068075__F3
ndex: e1941750-df09-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4068075__1939-4551-7-13-3.html
  '@type': Dataset
  description: Consequences of EMT on innate signaling. The innate NFkB pathway is
    composed of the rapidly responding (canonical)- and the slower responding (noncanonical)
    pathways. The canonical pathway controls the inflammatory response, and is coupled
    to the noncanonical pathway through a feed-forward pathway by the synthesis of
    TRAF1 and NFκB2, two rate limiting factors in noncanonical pathway activation.
    Through epigenetic reprogramming and enhanced transcriptional elongation through
    the cyclin dependent kinase (CDK), the rate-limiting TRAF1/NFκB2 translation is
    reduced, resulting in enhanced pathway activation in EMT.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Traf3
  - Slc22a3
  - Traf1
  - Rela
  - Nfkb1
  - Cdk9
  - Tnip1
  - Nfkb2
  - Il6
  - Twist1
  - MAP3K14
  - MAP4K4
  - TRAF3
  - ITK
  - SLC22A3
  - NFKBIA
  - TRAF1
  - RELA
  - NFKB1
  - CUX1
  - NFKB2
  - OAS3
  - PMEL
  - SART3
  - TPX2
  - SND1
  - ASCC2
  - FKBP4
  - GTF2H4
  - PMPCB
  - PSIP1
  - H3P42
  - CDK9
  - TNIP1
  - RELB
  - REL
  - CXCL8
  - IL6
  - TWIST1
  - SNAI1
  - SNAI2
  - SNAI3
  - Map4k4
  - Map3k14
  - Itk
  - Tpx2
  - Gtf2h4
  - Igbp1
  - Cxcl15
  - Cxcl1
  - Zeb1
  - traf3
  - traf1
  - rela
  - nfkb1
  - nfkb2
  - cdk9
  - tnip1
  - cxcl8a
  - il6
---
